| Application no. and date | 10709359.3 (espacenet) (Federated) (European Patent Register), 20100312 | | Patent/reg. no. and date | DK/EP 2406371, 20180509 | | Publication date | 20120118 | | Priority no. and date | US 160199 P, 20090313 | | EP pub. no. and date |
EP 2406371 20120118 | | Effective date | | | Applicant/owner | ALLERGAN, INC., 2525 Dupont Drive
Irvine CA 92612, US | | Applicant ref. no. | P65572DK01 | | Inventor | Fernandez-Salas, Ester, 1710 Rocky Road
Fullerton
CA 92831, US,
ZHU, Hong, 11408 Pacific Shores Way
San Diego
CA 92130, US,
WANG, Joanne, 37 Bristlecone
Irvine
CA 92620, US,
HODGES, D., Dianne, 14351 Pinewood Road
Tustin
CA 92780, US,
JACKY, Birgitte, P.S., 166 N. Waverly Street
Orange
CA 92866, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C12N 5/079 (2010.01) , C12Q 1/37 (2006.01) , G01N 33/50 (2006.01) | | Title | NYTTIGE CELLER TIL IMMUNBASEREDE BOTULINUMTOKSIN SEROTYPE A-AKTIVITETSTEST | | Int. application no. | US2010027242 | | Int. publication no. | WO2010105234 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
